Mirati Therapeutics, Inc. Research and Development Expenses 2013-2023 | MRTX

Mirati Therapeutics, Inc. research and development expenses from 2013 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
Mirati Therapeutics, Inc. Annual Research and Development Expenses
(Millions of US $)
2022 $532
2021 $509
2020 $299
2019 $183
2018 $94
2017 $58
2016 $68
2015 $49
2014 $26
2013 $20
2012 $15
2011 $9
Mirati Therapeutics, Inc. Quarterly Research and Development Expenses
(Millions of US $)
2023-09-30 $115
2023-06-30 $124
2023-03-31 $127
2022-12-31 $141
2022-09-30 $131
2022-06-30 $128
2022-03-31 $131
2021-12-31 $154
2021-09-30 $116
2021-06-30 $135
2021-03-31 $104
2020-12-31 $83
2020-09-30 $80
2020-06-30 $65
2020-03-31 $72
2019-12-31 $63
2019-09-30 $47
2019-06-30 $38
2019-03-31 $34
2018-12-31 $27
2018-09-30 $24
2018-06-30 $24
2018-03-31 $20
2017-12-31 $15
2017-09-30 $13
2017-06-30 $15
2017-03-31 $14
2016-12-31 $16
2016-09-30 $16
2016-06-30 $18
2016-03-31 $18
2015-12-31 $15
2015-09-30 $15
2015-06-30 $11
2015-03-31 $8
2014-12-31 $7
2014-09-30 $7
2014-06-30 $7
2014-03-31 $5
2013-12-31 $4
2013-09-30 $5
2013-06-30 $5
2013-03-31 $5
2012-12-31 $5
2012-09-30 $4
2012-06-30 $4
2012-03-31 $2